BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang K, Palma DA; IASLC Advanced Radiation Technology Committee. Follow-up of patients after stereotactic radiation for lung cancer: a primer for the nonradiation oncologist. J Thorac Oncol 2015;10:412-9. [PMID: 25695219 DOI: 10.1097/JTO.0000000000000435] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Latrèche A, Bourbonne V, Lucia F. Unrecognized thoracic radiotherapy toxicity: A review of literature. Cancer/Radiothérapie 2022. [DOI: 10.1016/j.canrad.2021.10.008] [Reference Citation Analysis]
2 Li Q, Liu Y, Su B, Zhao H, Lin Q, Zhu Y, Zhang L, Weng D, Gong X, Sun X, Xu Y. The CT appearance pattern of radiation-induced lung injury and tumor recurrence after stereotactic body radiation therapy in early stage non-small cell lung cancer. Transl Lung Cancer Res 2020;9:713-21. [PMID: 32676333 DOI: 10.21037/tlcr-20-609] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
3 Shu Z, Dong B, Shi L, Shen W, Hang Q, Wang J, Chen Y. Stereotactic body radiotherapy for elderly patients (≥ 75 years) with early-stage non-small cell lung cancer. J Cancer Res Clin Oncol 2020;146:1263-71. [PMID: 32095885 DOI: 10.1007/s00432-020-03154-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
4 Liu C, Zhao L, Wu F, Feng Y, Jiang R, Hu C. The multidisciplinary team plays an important role in the prediction of small solitary pulmonary nodules: a propensity-score-matching study. Ann Transl Med 2019;7:740. [PMID: 32042756 DOI: 10.21037/atm.2019.11.125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Brooks ED, Verma V, Senan S, De Baere T, Lu S, Brunelli A, Chang JY; International Association for the Study of Lung Cancer Advanced Radiation Technology Committee. Salvage Therapy for Locoregional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage NSCLC. J Thorac Oncol 2020;15:176-89. [PMID: 31712134 DOI: 10.1016/j.jtho.2019.10.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
6 Hiniker SM, Sodji Q, Quon A, Gutkin PM, Arksey N, Graves EE, Chin FT, Maxim PG, Diehn M, Loo BW Jr. FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot Study. Front Oncol 2019;9:467. [PMID: 31214507 DOI: 10.3389/fonc.2019.00467] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
7 Kwak YK, Park HH, Choi KH, Park EY, Sung SY, Lee SW, Hong JH, Lee HC, Yoo IR, Kim YS. SUVmax Predicts Disease Progression after Stereotactic Ablative Radiotherapy in Stage I Non-small Cell Lung Cancer. Cancer Res Treat 2020;52:85-97. [PMID: 31122008 DOI: 10.4143/crt.2019.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
8 Jo IY, Yeo SG. Stereotactic body radiation therapy for pulmonary large cell neuroendocrine carcinoma: a case report. Onco Targets Ther 2019;12:1359-64. [PMID: 30863102 DOI: 10.2147/OTT.S189858] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
9 Matsuo Y. A Systematic Literature Review on Salvage Radiotherapy for Local or Regional Recurrence After Previous Stereotactic Body Radiotherapy for Lung Cancer. Technol Cancer Res Treat 2018;17:1533033818798633. [PMID: 30198413 DOI: 10.1177/1533033818798633] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
10 Hasan S, Colonias A, Mickus T, VanDeusen M, Wegner RE. Image-based management of empiric lung stereotactic body radiotherapy (SBRT) without biopsy: Predictors from a 10-year single institution experience. Thorac Cancer 2018;9:699-706. [PMID: 29697204 DOI: 10.1111/1759-7714.12635] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
11 Li R, Chen G, Zhou L, Xu H, Tang F, Lan J, Tong R, Deng L, Xue J, Lu Y. The Fatty Acid Amide Hydrolase Inhibitor URB937 Ameliorates Radiation-Induced Lung Injury in a Mouse Model. Inflammation 2017;40:1254-63. [PMID: 28478515 DOI: 10.1007/s10753-017-0568-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Choi JI. Medically inoperable stage I non-small cell lung cancer: best practices and long-term outcomes. Transl Lung Cancer Res 2019;8:32-47. [PMID: 30788233 DOI: 10.21037/tlcr.2018.06.11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
13 Frakulli R, Salvi F, Balestrini D, Palombarini M, Akshija I, Cammelli S, Morganti AG, Zompatori M, Frezza G. Radiological differential diagnosis between fibrosis and recurrence after stereotactic body radiation therapy (SBRT) in early stage non-small cell lung cancer (NSCLC). Transl Lung Cancer Res 2017;6:S1-7. [PMID: 29299403 DOI: 10.21037/tlcr.2017.10.01] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
14 Kim K, Lee J, Cho Y, Chung SY, Lee JJB, Lee CG, Cho J. Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapy. Radiat Oncol J 2017;35:163-71. [PMID: 28712275 DOI: 10.3857/roj.2017.00066] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
15 Baker S, Dahele M, Lagerwaard FJ, Senan S. A critical review of recent developments in radiotherapy for non-small cell lung cancer. Radiat Oncol 2016;11:115. [PMID: 27600665 DOI: 10.1186/s13014-016-0693-8] [Cited by in Crossref: 75] [Cited by in F6Publishing: 87] [Article Influence: 12.5] [Reference Citation Analysis]
16 Bablekos GD, Analitis A, Michaelides SA, Charalabopoulos KA, Tzonou A. Management and postoperative outcome in primary lung cancer and heart disease co-morbidity: a systematic review and meta-analysis. Ann Transl Med 2016;4:213. [PMID: 27386487 DOI: 10.21037/atm.2016.06.02] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
17 Mattonen SA, Ward AD, Palma DA. Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply? Br J Radiol 2016;89:20160113. [PMID: 27245137 DOI: 10.1259/bjr.20160113] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
18 Sultan S, Ahmad S, Rave-Fränk M, Malik IA, Hess CF, Christiansen H, Cameron S. Induction of Lipocalin2 in a Rat Model of Lung Irradiation. Int J Mol Sci 2016;17:E637. [PMID: 27136530 DOI: 10.3390/ijms17050637] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
19 Lambrecht M, Melidis C, Sonke JJ, Adebahr S, Boellaard R, Verheij M, Guckenberger M, Nestle U, Hurkmans C. Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective. Radiat Oncol 2016;11:7. [PMID: 26791788 DOI: 10.1186/s13014-015-0567-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
20 Dejima H, Matsutani N, Imazuru T, Morita S, Takahashi Y, Shimokawa T, Kawamura M. Combined Aortic Resection and Stent Graft Insertion for Local Recurrence of Metastatic Lung Carcinoma Following Stereotactic Radiotherapy: A Case Report. Ann Thorac Cardiovasc Surg 2016;22:52-6. [PMID: 26256818 DOI: 10.5761/atcs.cr.15-00079] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]